Indivior Pharmaceuticals, Inc. INDV Business Segments — Net Income

Similar metrics at other companies

ADIReportable Segment — Net Income

$1.18B+106%

ADBEReportable Segment — Net Income

$1.71B+1.2%

CRDOReportable Segment — Net Income

$169.1M+362%

ZMReportable Segment — Net Income

$425.68M+67.2%

VEEVReportable Segment — Net Income

$260.94M+14.4%

DOCUReportable Segment — Net Income

$78.2M+8.5%

FAQ

What is Indivior Pharmaceuticals, Inc.'s business segments — net income?

Indivior Pharmaceuticals, Inc. (INDV) reported business segments — net income of $89M in Q1 2026.

How has Indivior Pharmaceuticals, Inc.'s business segments — net income changed year-over-year?

Indivior Pharmaceuticals, Inc.'s business segments — net income increased by 89.4% year-over-year, from $47M to $89M.

What is the long-term trend for Indivior Pharmaceuticals, Inc.'s business segments — net income?

Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc.'s business segments — net income has grown at a 68.1% compound annual growth rate (CAGR), from -$44M to $209M.

What does business segments — net income mean?

This represents the final profit or loss attributable to the reportable segment after all operating expenses, taxes, and non-operating items have been deducted. It is the definitive measure of the segment's overall financial success and value creation.